期刊文献+

2’-脱氧腺苷的合成 被引量:5

Synthesis of 2'-deoxyadenosine
下载PDF
导出
摘要 以腺嘌呤(Ⅰ)和1-乙酰氧基-3,5-二(对甲基苯甲酰基)-2-脱氧核糖(Ⅱ)为原料,先将腺嘌呤进行硅醚保护,然后与Ⅱ催化缩合生成带保护基的2’-脱氧腺苷,脱保护基,得到-βD-2’-脱氧腺苷。考察了反应物(Ⅰ)和(Ⅱ)的摩尔比、催化剂的用量及反应温度对2’-脱氧腺苷收率的影响。结果表明,最佳反应条件为:(Ⅰ)∶(Ⅱ)(摩尔比)=1∶1,催化剂用量为0.54%,反应温度为20℃时,2’-脱氧腺苷的总收率可达65%。 Abstract :2' -Deoxyadenosine was synthesized from adenosine(I) and 1-acetoxy-3,5-di (p-methyl-benzo- yl)-2-deoxy-ribose(Ⅱ). Adenosine was silyiated and condensated with raw charge (Ⅱ) to synthesized 2'- deoxyadenosine with protective group in the presence of special catalyst, then the protective group was eliminated in a controlling condition. The influences of other conditions including the mole ratio of reactant ( I ) to (Ⅱ) and amount of catalyst, temperature on yield of products were also discussed. Results showed the mole ratio of ( I ) to ( Ⅱ ) was 1 : 1, the amount of catalyst was 0.54%, the optimal reaction temperature was 20℃, the yield of 2' -deoxyadenosine achieved 65%.
出处 《应用化工》 CAS CSCD 2006年第7期564-565,568,共3页 Applied Chemical Industry
关键词 1-乙酰氧基-3 5-二(对甲基苯甲酰基)-2-脱氧核糖 腺嘌呤 2’-脱氧腺苷 合成 1 -acetoxy-3,5-di (p-methyl-benzoyl) -2-deoxy-ribose adenine 2' -deoxyadenosine synthesis
  • 相关文献

参考文献5

  • 1Robert K Ness,Hewitt G Fletcher,JR.A direct synthsis of 2'-deoxyadenosine and its anomer through 2-deoxy-d-ribose deriatives[J].J Am Chem Soc,1960,82:3434-3436.
  • 2吴耀文,蒋宇扬,付华,杨杰,赵玉芬.抗癌核苷类似物[J].有机化学,2003,23(10):1091-1098. 被引量:34
  • 3Worris J Robins,William A Bowles,Roland K Robins.Synthesis of 9-(2'-deoxy -α-and-β-D-ribofuranosyl and 2'-deoxy-α-and-β-d-ribopyranosyl)purines by the fusion method[J].J Am Soc Chem,1964,86:1251-1252.
  • 4Ralph A Lessor,Nelson J Lednard.Synthesis of 2'-deoxynucleosides by deoxyjenation of ribonucleosides[J].J Org Chem,1981,46:4300-4301.
  • 5Trelles J A,Fernandez M,Lew Kowicz E S,et al.Purine nucleoside synthesis from uridine using immobilized enterohacter gergoviae.CECT875 whole cells[J].Tetrahedron Letters,2003,44:2605-2609.

二级参考文献58

  • 1Matsuda A, Azuma A. Nucleoside Nucleotides 1995, 14(3-5), 461.
  • 2Obata T, Endo Y. Cancer Res. 1998, 123, 53.
  • 3Salam A K, Terry L B. Cancer Res. 1997, 57, 4803.
  • 4Gourdeau H, Clarke M L, Ouellet F, Mowles D,Selner M, Richard A, Lee N, Mackey J R, Young J D, Jolivet J, Lafreniere R G, Cass C E. Cancer Res.2001, 61(19), 7217.
  • 5Grove K L, Guo X, Liu S H, Gao Z, Chu C K,Cheng Y C. Cancer Res. 1995, 55, 3008.
  • 6Yin M B, Rusuan Y M. Cancer Comman. 1991, 3, 45.
  • 7Mandel H G. Cancer Treat Rep. 1981, 65(suppl. 3), 63.
  • 8Venturini M. Eur J Cancer 2002, 38, 3.
  • 9Pazdur R, Hoff P M, Medgyesy D, Royce M, Brito R. Oncology ( Huntingt ) 1998, 12 ( suppl. 7), 48.
  • 10Michael D S, Elmar N. Immunopharmacology 2000, 47,163.

共引文献33

同被引文献45

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部